INTRODUCTION
During the last 10 years, the diagnosis of agents of infectious disease has begun to include the use of nucleic acid-based technologies. Diagnosis of parasitic organisms is the last field of clinical microbiology to incorporate these techniques, due in part to the expense of new technology as well as a scarcity of these parasites in countries where this research is ongoing.
Despite the slow start on developing these assays, the further progress and utilization of nucleic acid-based assays to detect parasitic pathogens can and will play a role in the epidemiology, prevention, and treatment of parasitic diseases. In this review, only assays that have been described in the literature during the last 5 years will be discussed.
Nucleic acid-based probe detection of parasitic agents consists of the use of a reporter DNA molecule to detect specific parasite DNA or RNA sequences. The parasite within the target specimen is lysed with a membrane perturbant such as alkali, detergent, heat, chaotropic agents (urea and guanidine hydrochloride), or sonic disruption, and the nucleic acid is liberated and then denatured. The target sequence is detected by the reporter molecule following successful hybridization. The reporter molecule can be composed of an oligonucleotide, a DNA fragment, single-stranded DNA, or plasmid DNA. A label consisting of a radionucleotide, enzyme, antigenic molecule, affinity label, or chemiluminescent substrate is attached to the reporter. A positive signal is generated directly or indirectly by the reporter molecules that hybridized to target sequences in solution or immobilized on solid supports, such as filter paper, nitrocellulose, and nylon membranes. In 1985, a strategy for amplifying target DNA sequences via in vitro DNA replication was described (102) . PCR utilizes two oligonucleotides which flank the target sequence and a DNA polymerase, in successive cycles of denaturation and hybridization with oligonucleotide primers, followed by extension of the primers by action of the polymerase to generate billions of copies of the target sequence. The amplified target sequence is detected by probes as described above, or the DNA product can be analyzed directly by gel electrophoresis.
Currently, the detection and diagnosis of parasite infections rely on several methods in addition to clinical symptoms, clinical history, travel history, and geographic location of patient. Each diagnostic method has inherent advantages and disadvantages (Table 1) , irrespective of the type of parasite or clinical specimen being tested. The chief advantages of nucleic acid-based detection techniques are their sensitivity for detecting pathogens and the speed at which they can definitely identify an organism. If culture or animal inoculation is required for the identification of the parasite and the introduction of therapy, then probe detection or PCR offers an advantage. When direct microscopy is sufficient for parasite detection and species identification by morphology, and the level of parasite is sufficiently high, then nucleic acid-based technology is not advantageous except for processing a large number of specimens with an automated assay. However, when the parasite load is low, then a sensitive diagnostic test involving nucleic acids is beneficial. Serologic detection of antibodies to parasites is useful as a screening device, but often there are cross-reactive antigens compromising specificity, and serology generally does not discriminate between current active infection and either prior or latent infection. The results with nucleic acid-based assays are independent of immunocompetence or previous clinical history and can distinguish between organisms that are morphologically similar and/or share antigenic epitopes, and the organisms do not need to be viable or culturable. An inherent disadvantage of these assays is that isolates containing variant DNA sequences may be missed even though the sequence is not associated with virulence.
Development of Nucleic Acid-Based Diagnostic Assays
The first step in development of a nucleic acid-based detection assay is to identify and obtain the sequence of the target sequence (Fig. 1 ). The target sequence should be as specific to the organism as desired, i.e., either species or genus specific. In order to detect all isolates of that species, the sequence should not be polymorphic or demonstrate variability. If the sequence encodes a virulence factor or a structural protein, there is less likelihood of the target being genetically unstable. When sequences are present in multiple copies within the organism, such as rRNA genes, repetitive satellite DNA, and kinetoplast minicircle DNA, the analytical sensitivity of the assay will be greater (i.e., the detection limit will be lower). Often no suitable DNA sequences are available for a particular organism; therefore, they are isolated by screening a genomic DNA library for species-specific sequences and repetitive DNA sequences, using total genomic DNA as a probe. If PCR is being utilized, the next crucial step after the design of the oligonucleotide primers is to optimize the amplification parameters of the reaction with purified DNA. Optimizing the concentration of reaction components (magnesium chloride, DNA polymerase, nucleotide triphosphates, and primers) and selecting the temperature for annealing and the duration of time for each step of the thermal cycle will all influence the sensitivity and specificity of the reaction. Some investigators utilize nested PCR assays to increase sensitivity and specificity and delete the step of hybridization with a probe. In this procedure, an aliquot of the amplification products is subjected to another round of PCR with a set of primers located internal to the first set. In this procedure, it is very difficult to avoid false-positive reactions due to contamination of the second round of PCR with genomic DNA or amplified sequences. Sample contamination that can lead to a false-positive finding can result from sample-to-sample contamination, contamination from environmental sources of target sequence (plasmid DNA, in vitro culture, growth in animals, and insect vectors), or contamination with the aerosolized product of previous reactions. In addition to physical containment of amplified material, there are chemical and enzymatic methods to selectively inactivate amplified DNA (89) . Detection of the result from a positive amplification reaction requires the selection of a reporter molecule and a detection format. Historically, radiolabeled probes have been utilized because of their inherent high sensitivity. However, nonradioactive probes have several advantages, chiefly, their greater stability, which allows for standardizing reagents; and they are less hazardous to personnel and the environment, which simplifies disposal and monitoring systems. Following the selection and validation of the parameters for amplification, probe hybridization, signal detection, and definition of the cutoff for positive and negative reactions, it is necessary to determine the range of the assay in a specificity study. This study determines whether the assay detects and properly identifies strains isolated from a wide range of geographic locations and all known serotypes and excludes all other related organisms and organisms that might be present in the patient specimen or result in a similar clinical presentation. The analytical sensitivity of the assay should be determined by using whole organisms, if possible, or cloned target DNA or genomic DNA can be substituted.
Clinical or field performance depends on additional factors such as sample preparation, parasite load, and how, when, and what type of specimen was collected. Preparation of a biological sample for amplification and probe detection requires lysis and release of the nucleic acids, stabilization of the nucleic acids, efficient target recovery, and the removal of inhibitors of DNA polymerase activity and components that interfere with primer and probe hybridization to target sequences. Sample preparation is the step of nucleic acid-based assays that requires the most optimization and experimentation to develop a reliable process. If the method of sample preparation crudely lyses the parasites and does not purify the nucleic acids or target sequence, then either the target sequence needs to be present at high levels or only small amounts of inhibitors can be tolerated. Filtration and target capture procedures allow for analysis of larger volumes of specimen, but they are costly and inefficient and involve multiple steps. The selection of a sample preparation technique also depends upon the parasite level and the cellular and chemical composition of the patient specimens (see review of protocols in reference 43). In addition, when the level of parasites is low and/or the volume of specimen evaluated is small, sampling errors can occur. If a specimen contains approximately one organism and an assay has the ability to detect a single organism, Poisson distribution of the target will result in approximately one-third of the test reactions producing negative results.
For wide-scale adoption of a test, particularly in field trials, it is necessary to have a rapid, simple, inexpensive, and robust diagnostic assay. It is essential to eliminate radioactivity, hazardous materials, reliance on expensive equipment, and multiple laborious steps. The utility of an assay depends on the sensitivity and specificity of the assay with patient specimens, whether asymptomatic carriage of the organism which is not clinically relevant occurs, and whether the test is measuring a response to antimicrobial therapy. Furthermore, it is necessary to determine whether a nucleic acid-based assay is appropriate for the diagnosis or whether it is necessary to detect a toxin or gene product. Finally, the prevalence of the parasite of interest and other potential cross-reacting organisms in the patient population studied will determine the predictive value of the assay; thus, it is essential to test the performance and utility of an assay with the target patient population. The performance of the assay will be calculated in comparison with the current gold standard diagnostic technique for detecting the parasite. As mentioned above and in Table 1 , each diagnostic technique has different strengths and weaknesses, and thus discrepancies will occur. The best application of a PCR diagnostic assay will depend on many factors, including (but not restricted to) cost, speed, ease, performance, availability and performance of other diagnostic assays, and the need to directly detect and identify the parasite.
MALARIA
Molecular biologic techniques have been applied to the diagnosis of infections with the parasite genus Plasmodium for many years for several reasons. Four species of the parasitic protozoan Plasmodium infect humans (Plasmodium falciparum, P. vivax, P. malariae, and P. ovale); however, P. falciparum VOL. 8, 1995 DNA PROBES AND PCR TO DETECT PARASITES 115 is responsible for most of the morbidity and mortality. Accurate diagnosis of Plasmodium species is essential for successful treatment. The species do differ morphologically; therefore, microscopy is often used for diagnosis, but it suffers from poor sensitivity in cases of low-level parasitemia. In addition, two particular scenarios have encouraged the utilization of nucleicacid based technology in the diagnosis of Plasmodium DNA. One is the demonstration in certain geographic areas of several forms of drug-resistant P. falciparum that contain defined gene mutations, and the other is the discovery of variant P. vivax parasites that do not contain the circumsporozoite epitopes targeted by candidate vaccine preparations. Generally, microscopic examination of smears is adequate for diagnosis of the vast majority of cases of malaria.
Species Identification
The small-subunit rRNA genes contain both genus-and species-specific sequences that were the basis of a probe assay and two different PCR-based assays to detect and discriminate between human malarial parasites. When the rRNA molecules present in dried blood spots were the target of four speciesspecific oligonucleotide probes labeled with radioisotope, a sensitivity of only 10 to 50 parasites was obtained (130) . Snounou et al. (115, 116) used oligonucleotide primers specific to each species for specific amplification by PCR and detection of Plasmodium DNA, while Mathiopoulos et al. (72) described the use of genus-specific oligonucleotide primers in concert with species-specific probes to discriminate between the species. An improvement on sensitivity was obtained with a second round of amplification that used a set of internal primers in a nested PCR assay (116) . To detect mixed malarial infections with P. falciparum and P. vivax, genes encoding the circumsporozoite protein from each species were the basis of two independent PCR assays (16) . Studies in Thailand demonstrated that PCR-based assays detected higher proportions of mixed infections in blood than routine light microscopy whether blood-impregnated filter paper samples or DNA purified from whole blood ( Table 2 ) was used (16, 115, 116) . Parasite DNA was extracted from the filter paper by boiling in the presence of the chelating resin (Chelex-100). Replacing the organic extraction step of the DNA purification protocol with a boiling step reduced sensitivity (116) .
P. falciparum
The majority of the described nucleic acid-based assays to detect Plasmodium DNA have focused on the most virulent species, P. falciparum. The studies involving DNA hybridization probes chiefly utilized probes (short oligonucleotides, plasmid-borne fragments, and genomic DNA) that were homologous to the 21-bp repetitive sequences found throughout the P. falciparum genome, first described by Franzen et al. (39) . These probes did not hybridize to DNA of the other three human malaria species or human DNA. In general, the specificity of these assays was excellent (reviewed in reference 7); however, the sensitivity in comparison to that of microscopy was generally deficient, especially with patient samples having only low levels of parasitemia (4 to 550 parasites per l) (62) . In an analysis of in vivo drug susceptibility, the curve of microscopic parasite counts paralleled that of DNA hybridization signals, although values differed greatly between patients, indicating that accessibility to nucleic acids may also not have been optimal or uniform, although the DNA was purified from the blood samples (74) .
Numerous field studies that involved the use of these DNA probe assays with nonisotopic detection formats and improved sample preparation protocols were conducted. A 21-nucleotide synthetic probe complementary to the repeat sequence labeled with radioisotope or conjugated to alkaline phosphatase was tested with a large number of blood samples directly applied to filters (108) . The two probes performed similarly with these samples obtained from areas of Thailand where Plasmodium spp. are either endemic or nonendemic. The probes were highly specific but did not detect low levels of parasitemia (Ͻ500 parasites per l). When the synthetic probe conjugated to alkaline phosphatase was used and a protocol for microtiter plate-based blood lysis with detergent and protease followed by filtration was optimized for blood processing and storage and filter treatment (73, 75) , the sensitivity of the assay increased from 84 to 95%, while specificity remained excellent compared with microscopy. The patients were representatives of populations with high levels of parasitemia (The Gambia) and low levels of parasitemia with other species of Plasmodium present (Madagascar). The nonisotopic DNA assay kit produced results from 460 samples in a day, while microscopy required three people and several days (75) . A rapid blood lysis and filtration procedure to be used instead of a conventional phenol-chloroform extraction of DNA was developed with in vitro-cultured ring stage parasites and normal blood spiked with parasites (9) . Use of a radioactively labeled plasmid-borne fragment containing the 21-bp repeat sequence in concert with this lysis and filtration procedure resulted in 82% sensitivity (9) .
A different approach to increasing sensitivity and specificity of DNA probe assays utilized a reverse target capture assay with capture and reporter probes complementary to nonoverlapping regions of the target DNA (21) . Magnetic beads coated with a 30-nucleotide sequence from a 4-kb repeat unit captured the P. falciparum DNA, while a radiolabeled 21-bp repeat sequence specifically detected the bound parasite DNA. Sensitivity and specificity were increased by the inclusion of liquid-phase hybridization, magnetic separation of DNA-probe complexes, and successive cycles of capture and release. Only purified DNA was tested in the study, and modifications would be required prior to field testing, although the test was quite rapid and suitable for large numbers of specimens. In another variation, detection of P. falciparum parasitemia by probe hybridization to the abundant rRNA molecules was sensitive for parasites in culture (61) , and in field trials there was a general correlation between the amount of radiolabeled probe bound (quantitated by densitometry) and levels of parasitemia (131) . It was possible to correctly diagnose patients with low levels of parasitemia with the RNA probe and obtain a semiquantitative value for the level of parasitemia.
Once PCR became widely described, several investigators switched to designing PCR assays to detect P. falciparum because of the inherent increase in analytical sensitivity compared with that of DNA probe assays. In most cases, PCR proved to be significantly more sensitive than direct microscopic evaluation at detecting P. falciparum DNA in human blood ( Table 2) . Several different approaches to sample preparation have been explored. Barker et al. (8) designed degenerate primers based on the consensus sequence of eight 21-bp repeats. Amplification with these primers resulted in heterogeneously sized products. A study of patient blood samples indicated that there was a large number of discordant samples primarily with low-level parasitemia (Ͻ0.002%) compared with microscopy. PCR detected many specimens that were negative by microscopy, while PCR failed to detected others due to inhibition of amplification by components present in lysates. Additional membrane washes decreased the number of inhibitory samples. Comparisons of various methods for preparing blood samples for PCR (saponin lysis and filtration, saponin lysis and centrifugation, freeze-thaw, and direct spotting on membranes) were made, and saponin lysis followed by filtration through a membrane was chosen on the bases of ability to result in reproducible amplification results and technical ease. Direct spotting onto membranes was the easiest and simplest procedure; however, heme and its breakdown products are known PCR inhibitors, and blood also can contain unknown PCR inhibitors. The lysis and filtration protocol was similar to that successfully used in the field with a DNA probe assay (73, 75) .
Several other PCR assays to detect P. falciparum by using different approaches to increase sensitivity and specificity have been described. A nested PCR assay targeted to the P. falciparum dihydrofolate reductase-thymidylate synthase gene was tested in saponin-lysed blood samples from the Solomon Islands (129) . PCR was equivalent to microscopy for the few cases of parasitemia detected. In another PCR assay to detect P. falciparum DNA, intact parasites were purified and concentrated with immunomagnetic beads coated with antimerozoite surface protein antibodies (107) . The Pf155/RESA (ring-infected erythrocyte surface antigen) gene present in the captured parasites was amplified by nested PCR and colorimetrically detected in an enzyme-linked immunosorbent assay format. As expected, this method resulted in greater sensitivity than microscopy, particularly when the volume of blood analyzed was increased to the same volume (10 l) examined by the other PCR assays. Treating blood from experimental malarial infections with the chelating resin (Chelex-100) permitted direct analysis by PCR, but only a limited number of samples were evaluated (106) . Although PCR detection of P. falciparum was more sensitive in most of these assays than microscopic evaluation of blood smears, especially in cases of low-level parasitemia, generally microscopy produced adequate sensitivity and specificity (Table 2) . With low-level parasitemia, both techniques failed to detect parasites, and the presence of PCR inhibitors in a few patient specimens resulted in false-negative PCR results from samples with significant levels of parasites.
PCR has also been used to distinguish between different laboratory strains of P. falciparum and to detect mixed infections by analysis of polymorphic sequences encoding cell surface molecules containing regions of repeat sequences that vary in both length and sequence (136) .
P. vivax
DNA probes used for the detection of P. vivax were initially at least 10-fold less sensitive than those of P. falciparum (7), limiting usefulness since the levels of parasitemia are generally lower with P. vivax. The low sensitivity might have been due to low copy number of the DNA target, as the abundant rRNA molecules were detected with adequate sensitivity with a radiolabeled probe (130) . Subsequently, a radiolabeled P. vivax-specific repetitive sequence probe (VPL101/5) detected isolates from diverse geographic areas and performed adequately compared with microscopy (95) .
A variant of P. vivax, VK247, that produces a circumsporozoite protein distinct from the predominant circumsporozoite form has been detected worldwide in most P. vivax-endemic areas. Recombinant vaccines for P. vivax have targeted the central immunodominant region of the circumsporozoite which is altered in VK247. The detection and typing of P. vivax variant and immunodominant forms by PCR were evaluated. Amplification of the circumsporozoite gene from blood-impregnated filter paper allowed the detection and identification of the predominant and VK247 variant forms of P. vivax by use of variant-specific probes (58) . This PCR assay was used to assess the clearance of P. vivax strains in response to chloroquine therapy by comparison of amplification signals to a series of dilutions of control plasmid DNA (56) . Intrapatient changes in response to therapy were quantifiable, but interpatient comparisons were difficult due to the presence of unknown PCR inhibitors in blood from some patients. Accurate PCR quantitation of sample DNA depends on knowledge of the VOL. 8, 1995 DNA PROBES AND PCR TO DETECT PARASITES 117
on February 23, 2013 by PENN STATE UNIV http://cmr.asm.org/ level of PCR inhibitors present in the sample and the efficiency of amplification. Comparison of the amplification products of a DNA control added to the sample with control DNA standards can allow accurate quantitation. The P. vivax circumsporozoite PCR assay was further evaluated in a blind field study in Thailand, using blood spotted onto filter paper, comparing radioisotopic and nonisotopic detection systems (57) . The specificities of PCR and isotopic or enhanced chemiluminescent detection were 96 and 90%, respectively, compared with microscopy, while sensitivities were 96 and 91% (Table 2) . Enhanced chemiluminescent detection resulted in greater sensitivity than detection with colorimetric substrates. Dried blood-spotted filter paper samples have proven to be valuable for PCR analysis of Plasmodium spp. (16, (56) (57) (58) (59) but were suboptimal for serologic detection (59) . P. vivax resistance to chloroquine has been documented in several geographic areas, but the genetic basis has not been described.
Drug Resistance
For nearly 40 years, antifolate drugs (such as pyrimethamine and proguanil) were widely used in malaria prophylaxis and treatment. These drugs selectively inhibit Plasmodium dihydrofolate reductase. Antifolate resistance is increasingly common in areas where malaria is endemic. Specific point mutations that affect amino acid 108 in dihydrofolate reductase are responsible for the drug resistance in P. falciparum. Two assays that employed mutation-specific primers for PCR followed by electrophoretic analysis for the presence or absence of specific products have been described and can distinguish pyrimethamine-susceptible from drug-resistant as well as proguanil-resistant isolates (91, 140) . The assays differ in the primers used and the segments of the dihydrofolate reductase gene amplified. Analysis of archival patient blood samples indicated that detection could be achieved at levels of parasitemia commonly found in patient samples.
LEISHMANIA
Leishmaniasis is a group of infections of the viscera, skin, and mucous membranes caused by protozoa of the genus Leishmania. It is often a difficult disease to diagnose because of the low number of parasites found in clinical samples, the similar morphologies of Leishmania species, and the nondescript symptoms of the disease. Culture, which is difficult to perform, is often required for zymodyme analysis and to identify the species of Leishmania. Direct parasite detection is preferable to serologic tests, especially in areas of endemicity where populations are exposed to many trypanosomatids. Isolates have been traditionally assigned to species and subspecies on the bases of their geographic origin, the clinical syndrome they produce, and ecologic characteristics.
DNA probes for identifying Leishmania spp. have generally targeted kinetoplast DNA (kDNA) sequences. kDNA is a target of interest for diagnosis since both maxicircles and minicircles are present in each cell in multiple copies. It has proven difficult to select highly specific and sensitive kDNA sequences for diagnosis by DNA probe or PCR, since many of the sequences are conserved among different taxa, and within a clone several predominant minicircle classes will be present, not all of which will contain a particular sequence of interest. For these reasons, it is crucial to investigate only small regions of minicircles to find sequences that are species specific and conserved among strains of the same species. Most DNA probe assays required the use of cultured organisms or purified DNA and required a high level of parasites for sensitivity and specificity (reviewed in Table 3 and reference 7).
Visceral Leishmaniasis-L. donovani Complex
Visceral leishmaniasis (kala-azar) is found worldwide as a result of infection with parasites of the Leishmania donovani complex: L. donovani, L. infantum, and L. chagasi. A cDNA probe containing multiple copies of a 60-bp repetitive degenerate sequence (Lmet2) isolated from L. donovani specifically hybridized only to isolates of the L. donovani complex (53) . The sensitivity of probe hybridization was fewer than 100 organisms. A genomic DNA clone of repetitive sequences from L. infantum that differed from the above probe sequence was the basis for a PCR assay that detected purified DNA of members of the L. donovani complex as well as L. major (92) . A cloned fragment derived from the minicircle of a dermatotropic L. infantum strain showed only weak hybridization with L. donovani and L. chagasi DNA but detected both dermatotropic and viscerotropic strains of L. infantum (42) . Primers designed to amplify an entire L. donovani minicircle sequence successfully amplified parasite DNA extracted from splenic aspirates and peripheral blood samples of kala-azar patients; however, the assay was not specific for parasites of the L. donovani complex (114) . The detection of parasitemia by PCR exceeded diagnosis by microscopy. As little as 2.5 to 5 l of splenic aspirate was sufficient for diagnosis, while 50 to 500 l or more of blood was required due to lower parasite load. The ability to diagnose kala-azar with a peripheral blood sample would greatly facilitate treatment, since it was previously believed that there are only very low levels of circulating parasite, thus requiring invasive sampling of bone marrow or the spleen.
A subset of patients develop skin lesions following successful treatment of visceral leishmaniasis. The classification of organisms that cause this disease, termed post-kala-azar dermal leishmaniasis (PKDL), has been difficult due perhaps to the spectrum of disease presentation. In India, up to 20% of patients with visceral leishmaniasis develop PKDL, and the lesions usually appear 2 to 10 years after successful treatment, whereas in East Africa only 2% of patients are afflicted and lesions often appear within a few months of treatment. A clone derived from minicircle DNA of a PKDL isolate from India proved to be specific to the three PKDL isolates tested (also from India) and did not hybridize to L. donovani, while a clone derived from another region of the minicircle hybridized to many species of Leishmania (26) . When the Leishmania species present in several cases of PKDL from Sudan was identified through use of an rRNA-based PCR assay (125), L. donovani was discovered (34) .
Cutaneous Leishmaniasis in the Old World L. major, L. aethiopica, and L. tropica are the major causes of cutaneous leishmaniasis in the Old World. A DNA probe derived from minicircle DNA of L. major had only limited cross-hybridization with L. infantum and L. tropica and was not tested against L. aethiopica DNA, but cross-hybridization would be expected because of the presence in the probe of conserved origin of replication sequences (113) . In the same L. major clone, it was evident that there were several predominant minicircle sequences, not all of which hybridized to the kDNA probe. When clones of subfragments of the L. aethiopica kDNA minicircle were analyzed, they demonstrated several different patterns of species-specific hybridization: (i) for Old World species of Leishmania, (ii) for Old World cutaneous Leishmania species, (iii) for L. aethiopica and L. major but not L. tropica, and (iv) for L. aethiopica alone (63) . Some of the L. aethiopica-specific clones did not hybridize to all isolates of that species; however, they did not differentiate between isolates that caused localized or diffuse forms of disease.
New World Leishmaniasis: L. braziliensis and
L. mexicana Complexes Taxonomy of the New World Leishmania spp. has been subject to much revision on the basis of parasite behavior in culture or in the insect vectors, yet they have been divided into two groups: the L. braziliensis complex and the L. mexicana complex. The nontranscribed ribosomal spacer sequence of the ribosomal gene operon was the basis for an L. garnhamispecific probe (member of the L. mexicana complex) and an L. braziliensis complex-specific probe (47) . The L. garnhami probe hybridized with other members of the L. mexicana complex (L. mexicana, L. amazonensis, L. pifanoi, and L. venezuelensis) only under conditions of lessened stringency, whereas the L. braziliensis complex probe was specific for all species of the complex. The detection limit for these probes was approximately 100-fold lower than that of kDNA probes, in agreement with differences in copy number. By designing PCR primers that amplified the L. braziliensis complex nontranscribed ribosomal spacer sequence, the specificity was maintained while analytical sensitivity increased. Discrimination among species of the L. braziliensis complex was not possible.
One PCR assay that has good specificity and sensitivity for the detection of Leishmania spp. and uses simple and efficient methods of sample preparation and detection has been described. PCR primers designed to amplify a consensus sequence in minicircle DNA distinct from the replication origin specifically amplified DNA from members of the L. braziliensis complex (L. braziliensis, L. guyanensis, L. peruviana, and L. panamensis) and not other Leishmania species (68) . The analytic sensitivity of this assay was enhanced through incubation of the biopsy samples with the enzyme DNase I to decrease kDNA concatenation and the use of immobilized specific oligonucleotide probes to capture and detect PCR products colorimetrically. When crude extracts of 63 biopsy specimens obtained from patients with cutaneous and mucocutaneous lesions were analyzed in a field study in a remote Peruvian village, PCR resulted in more positive samples than conventional diagnostic methods (smear and/or culture). Diagnosis by PCR detected 87 to 100% of the culture-and/or smear-positive specimens. The concatenated nature of the trypanosomatid kDNA network presents an impediment to efficient primer annealing to target minicircle DNA. Chemical cleavage of the network (described in reference 65 for Trypanosoma cruzi) or enzymatic cleavage (described in reference 68 for L. braziliensis) can adversely affect amplification of long target sequences such as entire minicircles while enhancing amplification of short sequences.
Leishmania spp.
The multicopy 16S rRNA gene was the basis of two PCR assays that specifically detected all Leishmania spp. while excluding trypanosomes and Crithidia fasciculata (122, 125 ). An identification of the Leishmania sp. according to complex was achieved by DNA sequencing, restriction endonuclease analysis, or single-stranded conformation analysis of the amplified rRNA gene sequences (125) .
TRYPANOSOMES
Three species of protozoan parasites of the genus Trypanosoma are responsible for life-threatening diseases in humans: T. cruzi, the causative agent of Chagas' disease or American trypanosomiasis; and T. brucei rhodesiense, and T. brucei gambiense, the causative agents of African sleeping sickness.
Chagas' Disease: T. cruzi
In the initial phase of T. cruzi infection, large numbers of parasites circulate in the blood, and diagnosis is primarily by direct microscopic examination. In contrast, subsequent to acute infection and in chronic Chagas' disease, the circulating levels of parasite are below the limits of microscopy, and therefore detection and diagnosis rely on detecting the host serologic response or on xenodiagnosis. In xenodiagnosis, uninfected insect vectors, triatomine bugs, are allowed to feed on the patient, and a month later the bugs are examined for the presence of T. cruzi. Circulating trypomastigotes can be detected by xenodiagnosis in less than 50% of chronic patients with positive serology. The assays to detect serologic response VOL. 8, 1995 DNA PROBES AND PCR TO DETECT PARASITES 119
on February 23, 2013 by PENN STATE UNIV http://cmr.asm.org/ to T. cruzi suffer from poor specificity. Thus, a highly sensitive and specific assay is needed for diagnosis of chronic T. cruzi infection and for detection of the low levels of parasite present during the asymptomatic phase of infection. Genomic DNA and kDNA sequences have been used as DNA probes to detect T. cruzi, but the sensitivity and specificity were unsatisfactory (reviewed in reference 7) for the same reasons described above for the detection of Leishmania spp. Since the levels of circulating T. cruzi are low, the discovery of species-specific DNA sequences that are highly repetitive was key to the development of sensitive PCR-based diagnostic assays to detect T. cruzi (Table 4) . A conserved minirepeat sequence of kDNA minicircles shown to be species specific and strain independent was the basis for a PCR assay (4, 118) . Subsequently, a procedure using a guanidine-EDTA solution for lysing and storing whole blood, followed by cleavage of the kDNA network with a chemical nuclease to liberate free linearized minicircle DNA from concatenation, was described (6) . Since the minicircles were distributed throughout the lysate, only a small aliquot of the 10-ml volume of patient blood was needed for accurate PCR analysis. This greatly enhanced the sensitivity for detection of small numbers of T. cruzi in a large volume of blood, such as blood from patients with chronic Chagas' disease who were negative by xenodiagnosis. A panel of 114 blood samples from chronic chagasic patients and nonchagasic patients was screened for T. cruzi infection by PCR amplification, xenodiagnosis, and serologic tests (5). PCR amplification followed by Southern blot hybridization with a digoxigenin-labeled probe had 100% sensitivity compared with that of serologic testing, and the PCR method gave a positive result in all of the cases that were serologic test positive but xenodiagnosis negative. Specimens from only a few serology-negative patients were analyzed in this study, so the specificity of the PCR assay has not been adequately assessed. This study indicated the low level of sensitivity of xenodiagnosis and that PCR might be used as a confirmatory test for blood bank screening of seropositive specimens. In Latin and South America, blood transfusion can account for a significant number of cases of human T. cruzi infection, and infrequent cases of transfusion transmission occur globally. Serologic tests to detect specific antibody are not available at every site, and due to their high false-positivity rate, a confirmatory test such as xenodiagnosis is often advised.
A family of 195-bp repeat satellite DNA sequences that constitutes 9% of nuclear DNA was the target of another PCR assay. The assay had high analytical sensitivity and specificity for DNA purified from parasites or T. cruzi cells added to mouse cells but failed to detect parasite DNA in the blood of two patients with chronic Chagas' disease (82) . This result could have been due to intermittent parasitemia or to inhibitors of PCR that were present in the 2 ml of blood analyzed. The same primers successfully amplified T. cruzi DNA in 20 l of sera obtained from five acute and seven chronic chagasic patients in a study by different investigators (101) . T. cruzi parasites were isolated through hemoculture from blood of all of the patients except one, who had positive parasitemia by microscopy. Another group also chose satellite DNA as the basis for a PCR assay but selected different primers and used cell nuclei (from blood cells and parasites that were treated with the detergent Nonidet P-40) rather than whole blood as the source of parasite DNA (28) . They found that DNA extracted from whole blood was very inhibitory to PCR. The analytical sensitivity was increased 50-fold over the other 195-bp PCR assay, but no patient blood samples were evaluated. Another nuclear repetitive DNA sequence specific to T. cruzi, E13, was described, and primers were selected to amplify T. cruzi DNA (96) . The E13 element is polymorphic, and not all repeat units shared the oligonucleotide sequences, yet analytical sensitivity with purified T. cruzi DNA was comparable to those of other PCR assays. No human specimens were tested.
Another species of trypanosome, T. rangeli, produces asymptomatic infections in humans and has overlapping hosts and geographical distribution with T. cruzi. In addition, serologic assays demonstrate antigenic cross-reactivity between these two trypanosome species. The multicopy nuclear miniexon genes were the basis for a PCR assay that amplified DNA of both species but resulted in amplification products that differed in size (83) . Immobilized species-specific oligonucleotide probes were used in a dot blot assay for colorimetric detection and differentiation of the two species.
African Sleeping Sickness
The different subspecies of the African trypanosome T. brucei group (T. brucei rhodesiense, T. brucei gambiense, and T. brucei brucei) are morphologically identical but differ in the pathological effects of the disease they cause and their host ranges and geographical distributions, although exceptions have been noted. A set of primers targeted to a 177-bp highly repetitive sequence amplified DNA from T. brucei rhodesiense, T. brucei gambiense, and T. brucei brucei but not the animal pathogen T. congolense (81) . Two DNA-based techniques commonly used to discriminate between species were unable to reliably identify T. brucei rhodesiense and T. brucei gambiense: Southern blotting with repetitive DNA probes (radiolabeled rRNA gene probes [nontranscribed ribosomal spacer sequence 
TOXOPLASMA GONDII
The coccidian parasite T. gondii is responsible for widespread asymptomatic infection of the human population worldwide. This infection can cause significant morbidity and mortality in the developing fetus and when reactivated in the immunocompromised individual. Therefore, rapid and specific detection of the parasite within the host is required for accurate diagnosis and treatment, since serologic detection of a host response is inadequate. For these reasons, there has been significant research dedicated to the development of DNA-based diagnosis of T. gondii in human specimens (Table  5 ). Numerous PCR assays that target predominantly three different genes have been developed, and these assays have each been tested with small numbers of human specimens obtained from various body sites. No assay has been sufficiently optimized and validated with a large number of well-characterized specimens. The biology of toxoplasmosis in immunocompromised individuals is poorly understood, and the social sensitivities involved with diagnosing prenatal infection with T. gondii have contributed to the inconclusive results. There will be funds available for future testing to resolve the clinical utility and important applications for PCR diagnosis of T. gondii infection.
Gene Sequences
The first application of PCR to the detection of T. gondii followed the identification of a 35-fold repetitive gene (the B1 gene) by Burg et al. (18) . The oligonucleotide primers described, as well as the gene sequence, appeared specific for T. (13, 44, 85, 124) and nested sets of primers (126) . The gene encoding the major surface antigen, P30, was the target of two independent PCR-based assays (104, 134) , one of which used two sets of primers in a nested PCR assay to increase sensitivity (104) . The 110-fold repetitive small-subunit rRNA gene sequence was the basis for several PCR assays (20, 46, 69, 85) . Another repetitive DNA sequence, TGR1 E , was targeted in a PCRbased assay (25) . Two genomic cDNA clones were used as probes in dot blot hybridization analyses to detect parasite DNA (11, 137) . To differentiate T. gondii from closely related coccidia with similar host ranges, riboprinting (restriction enzyme analysis of PCR-amplified small-subunit rRNA gene sequences) was used (15) .
Toxoplasmosis in Immunocompromised Patients
Toxoplasmosis is one of the most common opportunistic infections in patients with AIDS and results from reactivation of a latent infection. Life-threatening encephalitis and/or a disseminated form of toxoplasmosis such as pneumonia can occur. Diagnosis of cerebral toxoplasmosis relies on clinical presentation, serologic evidence, and the discovery of cerebral lesions through computerized tomography. Diagnosis is confirmed if clinical and tomographic responses are observed with drug treatment or if parasites are directly detected in brain biopsies or cerebrospinal fluid (CSF). T. gondii DNA has been detected in the CSF of human immunodeficiency virus-positive patients suspected of having cerebrospinal toxoplasmosis, using a DNA probe specific for a repetitive DNA sequence (2) and PCR targeted to the repetitive B1 gene (44, 66, 85, 87, 105) . In a comparison of methods to prepare cell-rich CSF for PCR, lysis and digestion with proteinase K were superior to conventional DNA extraction, boiling, and DNA extraction and purification with guanidine and silica (44, 85) . Analysis of CSF using a nested PCR assay targeted to the B1 gene and a P30-based assay demonstrated that the former assay was significantly more sensitive with DNA purified from clinical specimens (126) . The number of patient CSF specimens evaluated was small in most studies. Negative results were obtained with CSF from patients having clinical evidence of toxoplasmic encephalitis when some of the DNA diagnostic tests were used (25, 44, 87, 105, 126) ; however, there is no gold standard for diagnosing cerebral toxoplasmosis. Many AIDS patients have positive T. gondii serology and neurologic disease, but it is very difficult to demonstrate that T. gondii is the causative agent of the neurologic disease. Antibodies can persist from a previous infection or result from latent cysts. Brain biopsy tissue (fresh and formalin fixed) from a few immunocompromised patients was the source of nucleic acids for B1 and P30 gene PCR assays that resulted in the positive identification of T. gondii; however, this type of specimen is generally available only postmortem (52, 124) .
In immunocompromised patients, disseminated forms of toxoplasmosis affecting the brain, lungs, and heart may occur. As mentioned above, a combination of serologic evidence, in vitro culture, and clinical presentation is presently required for diagnosis. Parasitemia may exist in immunocompromised patients prior to or during the course of cerebral toxoplasmosis. Pulmonary toxoplasmosis can be a cause of atypical pneumonia in AIDS patients. Bronchoalveolar lavage fluid analyzed by PCR, using several primer sets directed to the B1 and P30 genes, indicated a higher than expected prevalence of T. gondii and a greater sensitivity at detecting the parasite than microscopic detection (99) . Of 42 human immunodeficiency viruspositive patients with pulmonary symptoms, 6 were shown by competitive PCR assay to have T. gondii DNA in their bronchoalveolar lavage specimens (13) . All PCR-positive samples came from patients with extrapulmonary toxoplasmosis undetected at the time of lavage, while bronchoalveolar lavage samples from six patients with neurotoxoplasmosis undergoing drug therapy were negative by PCR, indicating drug efficacy. This PCR assay included an internal amplification control to monitor for PCR inhibitors in each specimen and enzymatic prevention of carryover amplicon contamination. A PCR assay targeted to the TGR1 E sequence detected T. gondii DNA in two bronchoalveolar lavage samples and a liver biopsy obtained from AIDS patients, indicating the occurrence of parasitic dissemination, yet one of these patients had no other evidence of toxoplasmosis (25) . Blood samples tested for parasitemia with PCR assays directed to the B1 and P30 genes showed great potential as noninvasive specimens for diagnosis of disseminated toxoplasmosis (31, 38, 54, 99) . PCR was more sensitive than cell culture and served to monitor the effects of drug treatment for presumptive cerebral toxoplasmosis (31) . A crude approximation of parasite level was obtained by analyzing the intensity of the PCR signal by both ethidium-stained gel and Southern blot analysis (31) .
Congenital Toxoplasmosis
Congenital toxoplasmosis is the result of transplacental transmission of parasite from an acutely infected mother, although most infected women do not transmit the infection to their offspring. Evaluation of the efficacy of DNA-based diagnostic assays for congenital infection is complicated since presently diagnosis utilizes amniotic fluid and/or fetal blood as a specimen. In addition, both fibroblast cell culture and mouse inoculation are often used for both specimens to obtain a reliable diagnosis. When a PCR assay targeted to the B1 gene was used in a large study of amniotic fluid specimens, although there was a problem with sporadic false-positive reactions, PCR was more sensitive than mouse inoculation or culture of amniotic fluid (45) . Evaluation of fetal blood by mouse inoculation or detection of specific immunoglobulin M was also less sensitive. However, there were a few false-negative PCR results, perhaps due to low numbers of parasites or substances that were inhibitory to PCR. The best results were obtained after centrifuging the amniotic fluid prior to boiling. An rRNA gene-based PCR assay was reported to produce no falsepositive or false-negative results with amniotic fluid as opposed to amniotic fluid culture or fetal blood examination; however, little experimental data were provided (20) . When a P30 PCR assay was applied to a spectrum of specimens associated with cases of acute maternal toxoplasmosis, the pattern of positive results by PCR and mouse inoculation was confusing (55) . Both apparent false-positive and false-negative results by PCR were observed. The false positives could have been a result of contamination, greater sensitivity of PCR compared with inoculation, or the detection of nonviable parasites.
Toxoplasmosis in Immunocompetent Persons
In nonimmunocompromised patients, acute infection with T. gondii can result in some disease-producing sequelae. Ocular toxoplasmosis is the most common cause of retinal inflammation in these patients. Both aqueous humor fluid and paraffinembedded ocular sections have been used as sources of DNA for PCR-based diagnosis of ocular toxoplasmosis (3, 14) . In all cases, no false positives were observed, but the sensitivity of the various PCR assays was poor, perhaps due to an inadequate amount of DNA subjected to analysis. Toxoplasmic lymphadenitis can occur during acute infection; generally, cysts are identified rarely, and diagnosis is by histology. When a PCR assay to detect the B1 gene was applied to DNA extracted from frozen tissue, it failed to detect T. gondii DNA in eight of the nine cases, indicating that few parasites were present (133) . Additionally, the blood specimens of 13 recently infected individuals were negative for T. gondii by PCR, yet positive results were obtained from patients with reactivated toxoplasmosis, suggesting that only transient parasitemia occurs during acute infection (54) . Recipients of cardiac transplants from toxoplasma-seropositive donors can acquire a severe, acute infection. Compared with histologic detection of cysts in cardiac tissue, PCR was more sensitive, although it did not distinguish between quiescent cysts and free trophozoites resulting from active infection (51) .
ENTAMOEBA HISTOLYTICA
The majority of people infected with the protozoan parasite, E. histolytica, become asymptomatic carriers, and only 10% develop symptoms of invasive amebiasis. Isolates from asymptomatic carriers are considered to be nonpathogenic, although cysts may be excreted. Diagnosis by microscopy frequently overestimates the prevalence of pathogenic E. histolytica because of the inability to distinguish pathogenic and nonpathogenic strains and the presence of morphologically similar species. Nonpathogenic isolates possess different isoenzyme patterns and have been shown during the last few years to be genetically distinct from pathogenic strains. Recently, separation of E. histolytica isolates into two species, the pathogenic E. histolytica and the nonpathogenic E. dispar, has been proposed (27) . Several genes that contain DNA sequences differing between pathogenic and nonpathogenic strains have been the basis for DNA-based assays to detect and identify E. histolytica.
Only two assays have been tested with patient samples (1, 103) .
E. histolytica-Pathogenic versus Nonpathogenic Isolates
Two highly abundant repetitive sequences present in extrachromosomal circular DNA molecules were shown through the use of DNA probe hybridization at high stringency to differentiate between pathogenic and nonpathogenic laboratory and clinical isolates (12, 40) . The 145-bp repeat sequence (P-145) found in pathogenic isolates demonstrated only 44% similarity with the 133-bp repeat sequence (B-133) of the nonpathogenic isolates. Actually, the 145-bp pathogenic repeat sequence was not entirely specific to pathogenic isolates, since a low number of copies was present in nonpathogenic isolates (12, 40, 80) . A DNA hybridization probe consisting of tandem repeats of P-145 had sufficient sensitivity (eight trophozoites) to detect parasites in stool samples that were subjected to several freeze-thaw cycles to release DNA; however, it did not distinguish between pathogenic and nonpathogenic isolates with the hybridization conditions used (103) . These 123 samples were obtained from symptomatic patients in Mexico City, Mexico, and the assay had a sensitivity of 100% and a specificity of 93% compared with microscopic diagnosis. More recently, two PCR-based assays were developed to detect these repeat sequences and to discriminate between pathogenic and nonpathogenic isolates utilizing two independent sets of primers and dot blot hybridization (1, 80) . One of these PCR assays was used in a field study in a rural Mexican community of randomly selected individuals to study the epidemiology of E. histolytica (1) . Nucleic acids were extracted from formalin-fixed stool specimens following three freeze-thaw cycles and sonication. The PCR products were detected and identified by dot blot hybridization analysis, using radiolabeled probes containing multiple repeat sequences. When results were compared with those of microscopic diagnosis, the PCR assay had a sensitivity of 96% and a specificity of 98%. Interestingly, many of the positive samples contained both pathogenic and nonpathogenic strains of E. histolytica.
Differential screening of cDNA libraries constructed from pathogenic strains has identified several sequences that have nonpathogenic homologs. Single-copy genomic DNA sequences encoding a 125-kDa surface antigen that differed between pathogenic and nonpathogenic isolates but were 90% similar in nucleic acid sequences made up the basis for differentiation of isolates by DNA probes and restriction enzyme fragment length polymorphism analysis of PCR products (33, 121) . A DNA clone isolated from a cDNA library containing 26-nucleotide tandem repeats was found to distinguish between xenically cultured pathogenic and nonpathogenic E. histolytica strains; however, this sequence was not present in all axenically cultured pathogenic strains (17) . Two pairs of oligonucleotide primers targeted to sequences coding for a 30-kDa surface antigen were the basis of a PCR assay discriminating between pathogenic and nonpathogenic laboratory isolates (120), while another 30-kDa assay featured multiple sets of primers and restriction enzyme analysis to differentiate pathogenic from nonpathogenic laboratory isolates (119) .
The small-subunit rRNA genes from pathogenic and nonpathogenic isolates are distinct, and these sequence differences were the basis for a test in which two independent sets of oligonucleotides were used to discriminate between the types (22, 24) . However, the nonpathogenic isolates produced a small amount of appropriately sized product from nonspecific priming of the nonpathogen gene with the pathogen-specific primers.
Identification of Entamoeba to Species Level
The human intestine can be colonized by several types of amoebae, including several species of Entamoeba; however, only E. histolytica is pathogenic. E. histolytica, E. dispar, and E. moshkovskii are morphologically indistinguishable. A DNA probe complementary to an rRNA sequence (175 to 200 copies per genome) distinguished between E. histolytica and the avirulent human amoeba previously designated E. histolyticalike Laredo type and now classified with E. moshkovskii (10) . The small-subunit rRNA gene was the basis for a ribotyping assay in which PCR amplification of the gene was followed by restriction fragment length polymorphism analysis wherein E. histolytica, E. coli, E. hartmanni, and E. moshkovskii could be differentiated (22, 23) .
Among the PCR assays described to detect E. histolytica, E. histolytica-like Laredo strain was not detected by some E. histolytica 30-kDa assays (119, 120) and was classified with the pathogenic E. histolytica by another 30-kDa assay and the 125-kDa assay (33, 119) .
GIARDIA LAMBLIA
Nucleic acid-based detection of G. lamblia cysts and trophozoites in fecal specimens has proven difficult due in part to the difficulty of lysing cysts and, more importantly, the large amount of other DNA and inhibitory substances present in these clinical specimens. DNA probes (both total genomic and clones) had detection limits of 10 4 to 10 5 purified trophozoites or cysts and were unable to detect parasites present in fecal specimens (19, 67) .
The technique of PCR has been applied to the analysis of G. lamblia nucleic acids for two purposes: (i) to detect genetic variation and differentiate among genotypes of G. lamblia and (ii) to distinguish between live and dead cysts. The genetic relationship between human isolates of G. lamblia and isolates from animals has been of interest for epidemiologic and taxonomic reasons. PCR analysis using primers targeted to the gene encoding the small-subunit rRNA gene (132) , a trophozoite surface antigen (37) , and repeat sequences and random sequences (123) all demonstrated that there was genetic variation among human isolates and that there was no distinguishing characteristic uniting the human isolates. Mahbubani et al. (70, 71) developed PCR-based assays targeted to the giardin gene to detect Giardia spp. or, specifically, G. lamblia cysts in environmental water samples. RNA-PCR performed to detect giardin mRNA before and after induction of excystation distinguished live from dead cysts, which is important for surveillance of water supplies (70) . Cysts that die during the water purification process should be excluded from the determination of health risk to water consumers.
Only Weiss et al. (132) applied PCR to the evaluation of human fecal samples. The sensitivity of the small-subunit rRNA PCR assay as applied to formalin-fixed fecal specimens resulted in some false-negative and false-positive results compared with microscopic detection. These discrepant results could be due to inefficient lysis of parasites, poor recovery of DNA during DNA extraction, inhibition of PCR by fecal components, sampling error, and the insensitivity of microscopic detection.
OTHER PROTOZOA

Trichomonas vaginalis
Diagnosis of T. vaginalis, the cause of widespread sexually transmitted disease in both men and women, primarily relies on direct microscopic examination of wet smears, which is relatively insensitive. A 2.3-kb T. vaginalis DNA fragment present in diverse geographic isolates was used as a radiolabeled probe to detect parasite DNA in a dot blot hybridization analysis of DNA extracted from vaginal discharge (100). The detection limit was 200 organisms, yet in an analysis of 98 clinical samples, the sensitivity of the assay exceeded that of standard microscopic examination and the specificity was also excellent. The Tv-560 family of repeat sequences was the target of a DNA probe that was species specific (86) . This probe detected T. vaginalis strains from diverse geographical areas in a dot blot hybridization analysis that did not require isolation of DNA. A suspension of axenically cultured T. vaginalis cells was lysed with alkali in situ on membranes, with a detection limit of 1,000 cells. Various genomic T. vaginalis sequences became the target of candidate primer sets for a PCR-based diagnostic assay (97) . Several of the amplification reactions were affected by genotypic variation among clinical isolates; however, one primer pair (detecting the A6p sequence) reacted with all 15 isolates tested and demonstrated species specificity. In this study, only 12 vaginal swab specimens were evaluated with lysed extracts of pelleted cellular material. PCR results analyzed by gel electrophoresis or dot blot hybridization correlated with microscopic examination of wet mount preparations, with one sample only positive by PCR.
Cryptosporidium parvum
C. parvum is now recognized as an important etiologic agent of human diarrhea, and the infection in immunocompromised patients can be prolonged and life threatening. Cryptosporidium spp. have been the etiologic agents of numerous disease outbreaks caused by the ingestion of contaminated water. The sensitivity of current diagnostic techniques for detecting oocysts is low owing to their dependence on concentration of the specimen (stool or environmental water) and specific oocyst staining. However, in acutely infected individuals the level of oocyst excretion can be very high. A 452-bp genomic DNA sequence specific to C. parvum was used as the basis for PCR amplification and chemiluminescent detection to detect parasite DNA present in fixed, paraffin-embedded tissues (64, 65) . This system would need modification to identify asymptomatic carriers. No assay to detect Cryptosporidium spp. in stool specimens or in environmental water has been described. As described for G. lamblia, for environmental surveillance it may be necessary to distinguish live from dead cysts in treated water sources.
Babesia microti
Infection with the tick-transmitted rodent pathogen, B. microti, can cause human babesiosis in a subset of the exposed human population. Definitive diagnosis is difficult due to the scarcity of the parasite in the blood during the acute phase of infection, and antibody tests do not distinguish between patients that have been exposed to the protozoa and those who are actively infected. Oligonucleotide primers and an internal chemiluminescent probe were designed to amplify and detect the B. microti small-subunit rRNA gene with an analytical sensitivity for three merozoites (90) . B. microti DNA was detected by PCR analysis in protease-and detergent-treated lysates prepared from blood of 12 patients with human babesiosis in a blinded test.
Naegleria fowleri
N. fowleri is a free-living amoeba which can cause acute and fatal meningoencephalitis in humans. Several other species of morphologically similar Naegleria can be found in the environment; thus, accurate identification is required for environmental monitoring. Primers targeted to a virulence-associated gene sequence were the basis of a PCR assay that specifically detected N. fowleri with a detection limit of a single cell (117) . An N. fowleri repetitive DNA sequence with homology to mitochondrial ATPase 6 genes was the basis for a PCR assay that cross-reacted with DNA of other Naegleria spp. (76, 117) . In a blind study, N. fowleri was detected in detergent-treated lysates of brain tissue from experimentally infected mice (76) .
FLUKES
Flukes are parasitic worms of the class Trematoda. There are intestinal, hepatic, pulmonary, and blood flukes that infect humans and cause endemic disease in many areas of the world. Only a few nucleic acid-based radioisotopic diagnostic assays for detecting these parasites have been described. Diagnosis generally relies on the microscopic detection of eggs, a procedure that is laborious and time-consuming but generally reliable in the hands of experienced personnel.
Schistosoma spp.
Of the many known species of Schistosoma, five regularly infect humans. In some geographic areas, the human pathogens coexist with species that are noninfective for humans but are morphologically similar. Species identification is of most importance for vector control. A cloned 600-bp DNA se-quence, Sm23, demonstrated a specificity for female Schistosoma mansoni schistosomes and did not react with seven other Schistosoma species tested (128) . Another cloned S. mansoni DNA sequence detecting a highly repetitive 121-bp genomic sequence demonstrated high analytical sensitivity (100 pg of DNA) and detected S. mansoni DNA present in total DNA from infected snails (48) . The probe also demonstrated partial cross-reactivity with S. haematobium. Use of one of a set of arbitrarily selected primers for the random amplification of polymorphic DNA analysis of schistosome DNA was found to result in an amplification pattern that was identical among five S. mansoni strains but different for all other Schistosoma species tested (84) .
Fasciola hepatica
A nucleic acid-based test to detect F. hepatica RNA has been developed to detect fluke nucleic acid in the infected snail vector (110) . An oligonucleotide probe complementary to the small-subunit rRNA gene was used to specifically detect F. hepatica RNA present in the total RNA isolated from infected snails.
Opisthorchis viverrini
A DNA probe that targeted a specific repetitive 340-bp sequence detected O. viverrini DNA present in egg-containing fecal specimens from patients with opisthorchiasis in a dot blot hybridization procedure (112) . The fecal specimens were treated with alkali, autoclaved, and then applied to membranes. This limited study of patient samples indicated that DNA was detected in samples with an egg count below 100/g.
ROUNDWORMS (NEMATODES)
There are thousands of species of parasitic nematodes that infect vertebrates. The species of intestinal, blood, and tissue nematodes that are parasitic to humans can range in length from 2 mm to 1 m. Diagnosis is generally by clinical symptoms, microscopic detection, and morphologic identification. The detection and identification of the filarial worms are very difficult due to the small size of the microfilariae and the periodicity of their presence in peripheral blood samples; thus, nucleic acid-based assays offer an advantage for detection of microfilariae.
Trichinella spiralis
The nematode T. spiralis can infect nearly all meat-eating animals. Serologic tests are poor indicators of infection; direct detection of the nematode in muscle is the most definitive diagnostic tool. Trichinellosis is transmitted within two cycles that can interact: a sylvatic cycle in wild animals, and a domestic cycle in swine which is the major source of human infection. Two different sets of PCR primers based on a 1.6-to 1.7-kb repetitive gene sequence (pPRA; present in 2,800 copies per genome) were developed to specifically identify domestic isolates, discriminating them from sylvatic isolates (29, 32) . It was possible to detect a single excysted larva, as well as a single encysted larva, in situ in infected mouse muscle following boiling (29) . It is unlikely that meat would be screened for T. spiralis with a nucleic acid-based assay because of the large amount of meat that would need to be screened to detect a single nematode.
Lymphatic Filariasis: Wucheria bancrofti and Brugia malayi
Human lymphatic filariasis is caused predominantly by the filarial worm Wucheria bancrofti and less often by Brugia malayi; B. timori accounts for very few cases. A repetitive gene sequence (IWb35) of W. bancrofti was the target of a PCRbased amplification and chemiluminescent detection assay that was specific for this filarial parasite (30) . It successfully detected parasite DNA present in infected mosquitoes but only after the parasite DNA was purified away from interfering mosquito components with a biotin-labeled DNA capture fragment (IWb67) that hybridized to genomic DNA from most filarial species and avidin beads were used to isolate the DNA hybrids. After being washed, the captured DNA was eluted and used for PCR analysis. A cloned genomic sequence with homology to myosinlike myofibrillar proteins was the basis for the design of primers that detected DNA from one microfilaria of either B. malayi or W. bancrofti but, unexpectedly, not other closely related filarial species such as B. pahangi, which is found in many animal species and can infect humans experimentally (94) . A probe based on a genomic repetitive sequence, pBM15, hybridized to B. malayi and cross-hybridized to B. timori but not to B. pahangi or W. bancrofti, although only a few isolates were assayed (111). In a dot blot hybridization assay using radiolabeled probe, a sensitivity of detection of one microfilaria or larva was achieved.
Unit-length DNA probes that detected sequences of the Brugia highly abundant 322-bp HhaI repeat DNA sequence family (30,000 copies per genome) did not discriminate between B. malayi and B. pahangi DNA (77) . Although the B. malayi and B. pahangi cross-hybridizing HhaI repeat sequences are polymorphic, it was possible to design species-specific consensus oligonucleotide probes based on regions of divergence between the species that discriminated between B. malayi and B. pahangi under stringent hybridization conditions (135) . A simple procedure for filtration and lysis (using alkali, protease, and detergent) of blood samples prior to hybridization with these specific radiolabeled filarial oligonucleotide probes was developed, found to have a sensitivity of detection of one microfilaria, and validated with blood specimens from 45 infected jirds (93) .
Loa loa
The filarial parasite, L. loa, can cause migratory angioedema and chronic infection in some microfilaremic patients. DNA corresponding to a region of satellite DNA with many copies of a hexamer repeat was found to be specific for L. loa when either a oligonucleotide probe was used for hybridization or the DNA was targeted with oligonucleotide primers for PCR analysis (60) . When 1-ml aliquots of peripheral blood containing L. loa were filtered onto membranes and lysed using the field-applicable technique developed by Poole and Williams for detection of Brugia spp. (93) , the enhanced chemiluminescent probe assay detected one microfilaria (60) . ochengi-specific probes were tested on larvae isolated from wild flies trapped in an area undergoing vector control, and the results indicated that none of the larvae were O. volvulus and that the majority were O. ochengi (139) . As a result, larvicide use in the area was suspended.
Onchocerca volvulus
TAPEWORMS (CESTODES)
The adult stage of tapeworms inhabits the intestinal tract of vertebrates, causing minimal intestinal irritation and few, if any, systemic effects. Tapeworm larvae inhabit tissues of both vertebrates and invertebrates. When ingested, the larvae can cause serious symptomatic disease due to space-occupying lesions.
Taenia
Tapeworms of the genus Taenia can cause both human taeniasis and cysticercosis. The adult stage of Taenia solium and T. saginata can infect humans, causing taeniasis, while only T. solium can produce human infection in the larval stage, resulting in cysticercosis. The eggs from the two species cannot be differentiated morphologically. A 500-bp probe sequence (pTS10) which hybridized specifically to a single-copy T. solium gene sequence and not to T. saginata DNA has been identified (98) .
Echinococcus
The larval stage of several species of Echinococcus can cause serious human disease. The alveolar cyst of Echinococcus multilocularis is the causative agent of alveolar echinococcosis. A genomic DNA sequence (pAL1) was the source of sequences for two PCR-based assays: one detected DNA of E. multilocularis and not E. granulosus (a fragment of a different length was produced with some Taenia species), and the other detected all Echinococcus species tested and no other cestodes (41) .
CONCLUSIONS
A review of the progress towards the development and testing of diagnostic assays that utilize nucleic acids to detect parasites revealed that, although many systems have been developed, few have proceeded towards field trials or largescale clinical evaluation ( Table 6 ). None of these PCR assays is sufficiently simple, robust, reproducible, or validated for widespread use in its present configuration. In part, this is due to the long time it takes to develop diagnostic assays that use new technologies and to the facts that PCR has become routine only in research laboratories and oligonucleotide synthesis has become inexpensive only in recent years. Introduction of the use of PCR in the diagnostic assays resulted in greatly increased analytical sensitivity and specificity over DNA probe assays. For DNA probe assays to attain high sensitivity, it was generally necessary to enhance signals through the use of radiolabeled reporter molecules. This is unacceptable for field use. New sensitive nonisotopic molecules for labeling reporter molecules that produce enhanced chemiluminescence and fluorescence are now available and may revitalize use of DNA probe assays, such as those used to detect Plasmodium DNA that showed potential in field trials (75, 108, 131) . Most of the assays to detect parasites targeted highly repetitive sequences in order to attain high analytical sensitivity with purified DNA; however, advances in sample preparation and detection of amplified sequences under field or clinical laboratory conditions will be necessary in order to achieve high sensitivity with human specimens. The assays described by Barker et al. (8) and Lopez et al. (68) to detect P. falciparum and L. braziliensis, respectively, were the only assays tested in toto in the field. The performance of these two assays was very encouraging in light of their use of simple, robust, sample-processing protocols and nonisotopic detection formats. Predictions for the future use and performance of the other described assays are difficult due to their early stages of research and development.
For routine diagnosis of human parasitic infections, PCR will most likely not become the standard diagnostic test, with a few exceptions such as the detection of reactivated T. gondii infections in patients with AIDS, detection of mixed P. falciparum and P. vivax infections, differentiation of pathogenic and nonpathogenic E. histolytica, and detection of variants (including drug-resistant Plasmodium spp.). In these exceptions, either the parasite level is extremely low, differentiation between morphologically identical organisms is required, or the immune response to the parasite infection is uninformative. PCR-based diagnosis will be too expensive and technically demanding for use in developing countries where the per capita expenditure for total health care is very low. Automation of various steps (sample preparation and processing, amplification, and detection) and the commercial availability of reagents and products would impact on widespread use. However, these techniques will and already have played a role in studies of the epidemiology, taxonomy, and pathogenesis of parasite infection in humans. One of their most important contributions to controlling morbidity is in the identification of parasite-harboring vectors and the prevention of parasitic disease through vector control, such as the campaign to control onchocerciasis by monitoring the level of O. volvulus in black flies.
